(Q34107346)

31 July 2017

1 reference

title

Cholesterol, stroke risk, and stroke prevention (English)

1 reference

31 July 2017

Ansell BJ

1

1 reference

31 July 2017

1 March 2000

1 reference

Current Atherosclerosis Reports

31 July 2017

1 reference

31 July 2017

2

1 reference

31 July 2017

2

1 reference

31 July 2017

92-96

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-000-0101-5

31 July 2017

0 references

cites work

Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0101-5

High-density lipoprotein cholesterol and risk of ischemic stroke mortality. A 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0101-5

Influence of cholesterol on survival after stroke: retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0101-5

Cholesterol reduction and the risk for stroke in men. A meta-analysis of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0101-5

Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0101-5

Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0101-5

Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0101-5

Vascular effects of statins in stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0101-5

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0101-5

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

21 January 2018

1 reference

12 December 2020

An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program

1 reference

12 December 2020

Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials

1 reference

12 December 2020

Risk factor modification in stroke prevention: the experience of a stroke clinic

1 reference

12 December 2020

Treatment patterns and distribution of low-density lipoprotein cholesterol levels in treatment-eligible United States adults

1 reference

12 December 2020

An overview of trials of cholesterol lowering and risk of stroke

1 reference

12 December 2020

Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials

1 reference

12 December 2020

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

1 reference

12 December 2020

Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association

1 reference

12 December 2020

Clinical outcomes in statin treatment trials: a meta-analysis

1 reference

12 December 2020

Low total serum cholesterol and intracerebral hemorrhagic stroke: is the association confined to elderly men? The Kaiser Permanente Medical Care Program

1 reference

12 December 2020

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

12 December 2020

HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data

1 reference

12 December 2020

Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group

1 reference

12 December 2020

Low serum cholesterol as a risk factor for hemorrhagic stroke in men: a community-based mass screening in Okinawa, Japan

1 reference

12 December 2020

Lipids and stroke: neglect of a useful preventive measure?

1 reference

12 December 2020

Lipoprotein (a) and apolipoprotein E epsilon 4 as independent risk factors for ischemic stroke.

1 reference

12 December 2020

Blood pressure, stroke, and coronary heart disease

1 reference

12 December 2020

Low-Density Lipoprotein Cholesterol and the Risk of Dementia With Stroke

1 reference

12 December 2020

Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II)

1 reference

12 December 2020

Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial

1 reference

12 December 2020

Blood pressure, cholesterol, and stroke in eastern Asia. Eastern Stroke and Coronary Heart Disease Collaborative Research Group

1 reference

12 December 2020

Risk factors for new thromboembolic stroke in patients > or = 62 years of age with chronic atrial fibrillation

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Reductase inhibitor monotherapy and stroke prevention

1 reference

12 December 2020

Results of the primary outcome measure and clinical events from the Asymptomatic Carotid Artery Progression Study

1 reference

12 December 2020

10.1007/S11883-000-0101-5

Identifiers

DOI

1 reference

PubMed ID

11122730

Dimensions Publication ID

31 July 2017

0 references

1 reference

PubMed ID

11122730